TickerFacts.

Integra Lifesciences Holdings Corp (IART): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

$203.22M
Year ended 2019-12-31
+2.6%
3-year compound annual growth
+12.2%
5-year compound annual growth
$221.73M2008-12-31: $78.13M2009-12-31: $137.51M2010-12-31: $137.87M2011-12-31: $105.08M2012-12-31: $126.39M2013-12-31: $66.39M2014-12-31: $114.29M2015-12-31: $138.45M2016-12-31: $188.00M2017-12-31: $133.75M2018-12-31: $221.73M2019-12-31: $203.22M$203.22M
2008-12-31 EBITDA (USD) 2019-12-31
Period endedEBITDAChange YoYSource filing
2019-12-31$203.22M-8.3%2022-02-24, From 2019-01-01
2018-12-31$221.73M+65.8%2021-02-23, From 2018-01-01
2017-12-31$133.75M-28.9%2020-02-21, From 2017-01-01
2016-12-31$188.00M+35.8%2019-02-26, From 2016-01-01
2015-12-31$138.45M+21.1%2018-03-01, From 2015-01-01
2014-12-31$114.29M+72.2%2017-02-23, From 2014-01-01
2013-12-31$66.39Mn/c2016-02-26, From 2013-01-01
2012-12-31$126.39M+20.3%2015-02-27, From 2012-01-01
2011-12-31$105.08M-23.8%2014-02-27, From 2011-01-01
2010-12-31$137.87M+0.3%2013-02-26, From 2010-01-01
2009-12-31$137.51M+76.0%2012-02-27, From 2009-01-01
2008-12-31$78.13Mn/a2011-02-24, From 2008-01-01